|
IDH2-DT expression profile based on
|
BRCA : Breast invasive carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.92051598839171E-15
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.10318868735755E-06 |
| Normal-vs-Stage2 |
8.64048753403341E-11 |
| Normal-vs-Stage3 |
2.05583315614438E-07 |
| Normal-vs-Stage4 |
1.171841E-01 |
| Stage1-vs-Stage2 |
4.843724E-01 |
| Stage1-vs-Stage3 |
1.774314E-01 |
| Stage1-vs-Stage4 |
8.756212E-01 |
| Stage2-vs-Stage3 |
3.552537E-01 |
| Stage2-vs-Stage4 |
9.171110E-01 |
| Stage3-vs-Stage4 |
7.210643E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.87602380306767E-09 |
| Normal-vs-AfricanAmerican |
1.33615666750511E-07 |
| Normal-vs-Asian |
1.845536E-04 |
| Caucasian-vs-AfricanAmerican |
6.652572E-04 |
| Caucasian-vs-Asian |
4.553465E-02 |
| AfricanAmerican-vs-Asian |
3.474414E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.303524E-01 |
| Normal-vs-Female |
3.25283824768078E-15 |
| Male-vs-Female |
9.798397E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.235776E-02 |
| Normal-vs-Age(41-60Yrs) |
1.77395283603156E-10 |
| Normal-vs-Age(61-80Yrs) |
1.19611739039506E-10 |
| Normal-vs-Age(81-100Yrs) |
2.032197E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.121280E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.221010E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.299493E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.674337E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.368990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.812660E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Pre-menopause |
1.845275E-03 |
| Normal-vs-Peri-menopause |
1.218474E-01 |
| Normal-vs-Post-menopause |
3.18196181344723E-15 |
| Pre-menopause-vs-Peri-menopause |
5.951875E-01 |
| Pre-menopause-vs-Post-menopause |
2.801855E-01 |
| Peri-menopause-vs-Post-menopause |
1.720768E-01 |
|
|
| Subtype descriptions |
| IDC | Infiltrating Ductal Carcinoma |
ILC | Infiltrating Lobular Carcinoma |
| Mixed | Mixed histology |
Mucinous | Mucinous Carcinoma |
| Medullary | Medullary Carcinoma |
Metaplastic | Metaplastic Carcinoma |
| INOS | Infiltrating Carcinoma NOS |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-IDC |
4.19161060591515E-16 |
| Normal-vs-ILC |
5.751286E-04 |
| Normal-vs-Mixed |
1.093888E-01 |
| Normal-vs-Other |
2.477761E-01 |
| Normal-vs-Mucinous |
4.58520026889145E-05 |
| Normal-vs-Metaplastic |
9.981266E-01 |
| Normal-vs-INOS |
3.533756E-01 |
| Normal-vs-Medullary |
NA |
| IDC-vs-ILC/td>
| 4.323998E-03 |
| IDC-vs-Mixed |
8.838138E-01 |
| IDC-vs-Other |
2.163507E-02 |
| IDC-vs-Mucinous |
2.11005239228373E-27 |
| IDC-vs-Metaplastic |
3.923850E-04 |
| IDC-vs-INOS |
5.91437431616389E-05 |
| IDC-vs-Medullary |
NA |
| ILC-vs-Mixed |
4.049599E-01 |
| ILC-vs-Other |
5.008349E-01 |
| ILC-vs-Mucinous |
1.32104165033047E-09 |
| ILC-vs-Metaplastic |
3.332627E-02 |
| ILC-vs-Mixed |
3.083932E-03 |
| ILC-vs-INOS |
NA |
| ILC-vs-Medullary |
2.857103E-01 |
| Mixed-vs-Other |
3.241269E-02 |
| Mixed-vs-Mucinous |
1.194344E-01 |
| Mixed-vs-Metaplastic |
7.230699E-02 |
| Mixed-vs-INOS |
NA |
| Mixed-vs-Medullary |
1.184051E-02 |
| Other-vs-Mucinous |
3.251028E-01 |
| Other-vs-Metaplastic |
1.193769E-01 |
| Other-vs-INOS |
NA |
| Other-vs-Medullary |
7.329117E-02 |
| Mucinous-vs-Metaplastic |
1.898184E-01 |
| Mucinous-vs-INOS |
NA |
| Mucinous-vs-Medullary |
5.087558E-01 |
| Metaplastic-vs-INOS |
NA |
| Metaplastic-vs-Medullary |
NA |
|
|
| Subtype descriptions |
| TNBC-BL1 | TNBC-Basal like 1 |
TNBC-BL2 | TNBC-Basal like 2 |
| TNBC-LAR | TNBC-luminal androgen receptor |
TNBC-IM | TNBC-immunomodulatory |
| TNBC-MSL | TNBC-mesenchymal stem–like |
TNBC-M | TNBC-mesenchymal |
| TNBC-UNS | TNBC-unspecified |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Luminal |
1.42246066845714E-08 |
| Normal-vs-HER2positive |
3.57417690173271E-06 |
| Normal-vs-TNBC-BL1 |
2.153909E-02 |
| Normal-vs-TNBC-BL2 |
1.235345E-01 |
| Normal-vs-TNBC-LAR |
1.049917E-02 |
| Normal-vs-TNBC-IM |
1.257594E-02 |
| Normal-vs-TNBC-M |
5.598137E-02 |
| Normal-vs-TNBC-MSL |
3.473669E-01 |
| Normal-vs-TNBC-UNS |
2.130525E-01 |
| Luminal-vs-HER2positive |
2.574334E-03 |
| Luminal-vs-TNBC-BL1 |
2.084543E-01 |
| Luminal-vs-TNBC-BL2 |
3.469077E-01 |
| Luminal-vs-TNBC-LAR |
1.749858E-02 |
| Luminal-vs-TNBC-IM |
9.254641E-02 |
| Luminal-vs-TNBC-M |
2.531364E-01 |
| Luminal-vs-TNBC-MSL |
4.684649E-01 |
| Luminal-vs-TNBC-UNS |
8.864988E-01 |
| HER2Positive-vs-TNBC-BL1 |
5.865116E-01 |
| HER2Positive-vs-TNBC-BL2 |
9.316884E-01 |
| HER2Positive-vs-TNBC-LAR |
3.948996E-02 |
| HER2Positive-vs-TNBC-IM |
8.097974E-01 |
| HER2Positive-vs-TNBC-M |
9.387395E-04 |
| HER2Positive-vs-TNBC-MSL |
7.189043E-01 |
| HER2Positive-vs-TNBC-UNS |
1.664297E-01 |
| TNBC-BL1-vs-TNBC-BL2 |
8.222414E-01 |
| TNBC-BL1-vs-TNBC-LAR |
3.069914E-02 |
| TNBC-BL1-vs-TNBC-IM |
5.505971E-01 |
| TNBC-BL1-vs-TNBC-M |
1.069046E-01 |
| TNBC-BL1-vs-TNBC-MSL |
6.331206E-01 |
| TNBC-BL1-vs-TNBC-UNS |
4.425302E-01 |
| TNBC-BL2-vs-TNBC-LAR |
4.346918E-02 |
| TNBC-BL2-vs-TNBC-IM |
8.200032E-01 |
| TNBC-BL2-vs-TNBC-M |
2.456906E-01 |
| TNBC-BL2-vs-TNBC-MSL |
7.071256E-01 |
| TNBC-BL2-vs-TNBC-UNS |
4.524521E-01 |
| TNBC-LAR-vs-TNBC-IM |
4.849697E-02 |
| TNBC-LAR-vs-TNBC-M |
1.435984E-02 |
| TNBC-LAR-vs-TNBC-MSL |
2.629086E-01 |
| TNBC-LAR-vs-TNBC-UNS |
1.871515E-02 |
| TNBC-IM-vs-TNBC-M |
5.056122E-02 |
| TNBC-IM-vs-TNBC-MSL |
7.741474E-01 |
| TNBC-IM-vs-TNBC-UNS |
2.177952E-01 |
| TNBC-M-vs-TNBC-MSL |
4.197192E-01 |
| TNBC-M-vs-TNBC-UNS |
5.901780E-01 |
| TNBC-MSL-vs-TNBC-UNS |
4.921058E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Luminal |
1.42246066845714E-08 |
| Normal-vs-HER2Positive |
3.57417690173271E-06 |
| Normal-vs-TNBC |
1.03335545356331E-06 |
| Luminal-vs-HER2Positive |
2.574334E-03 |
| Luminal-vs-TNBC |
8.766417E-03 |
| HER2Positive-vs-TNBC |
4.916974E-01 |
|
|
